SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q X QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2001 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-30270 CROMPTON CORPORATION (Exact name of registrant as specified in its charter) Delaware 52-2183153 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) One American Lane, Greenwich, Connecticut 06831-2559 (Address of principal executive offices) (Zip Code) (203) 552-2000 (Registrant's telephone number, including area code) Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES X NO The number of shares of common stock outstanding is as follows: Class Outstanding at October 31, 2001 Common Stock - $.01 par value 113,009,782 CROMPTON CORPORATION AND SUBSIDIARIES FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2001 INDEX PAGE PART I. FINANCIAL INFORMATION Item 1. Financial Statements and Accompanying Notes Consolidated Statements of Operations (Unaudited) - Third quarter and nine months ended 2001 and 2000 2 Consolidated Balance Sheets - September 30, 2001 (Unaudited) and December 31, 2000 3 Consolidated Statements of Cash Flows (Unaudited) - Nine months ended 2001 and 2000 4 Notes to Consolidated Financial Statements (Unaudited) 5 Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 9 Item 3. Quantitative and Qualitative Disclosure of Market Risk 15 PART II. OTHER INFORMATION Item 1. Legal Proceedings 16 Item 6. Exhibits and Reports on Form 8-K 17 Signatures 18 CROMPTON CORPORATION AND SUBSIDIARIES Consolidated Statements of Operations (Unaudited) Third quarter and nine months ended 2001 and 2000 (In thousands of dollars, except per share data) Third quarter ended Nine months ended 2001 2000 2001 2000 Net sales $ 651,921 $ 738,456 $ 2,113,889 $ 2,310,360 Cost of products sold 454,608 510,914 1,472,197 1,559,424 Selling, general and administrative 105,105 95,736 316,810 318,482 Depreciation and amortization 46,887 45,284 140,604 135,968 Research and development 20,973 20,609 62,206 66,145 Facility closures, severance and related costs (a) 95,936 - 95,936 - Equity (income)loss 2,342 701 (5,466) (10,833) Operating profit (loss) (73,930) 65,212 31,602 241,174 Interest expense 27,277 30,944 83,762 88,839 Other expense 1,692 2,803 4,389 5,076 Earnings (loss) before income taxes (102,899) 31,465 (56,549) 147,259 Income taxes (benefit) (34,691) 9,905 (18,005) 54,485 Net earnings (loss) $ (68,208) $ 21,560 $ (38,544) $ 92,774 Basic earnings (loss) per common share $ (.60) $ .19 $ (.34) $ .81 Diluted earnings (loss) per common share $ (.60) $ .19 $ (.34) $ .81 Dividends declared per common share $ .05 $ .05 $ .15 $ .15 (a) Excludes $7,135 included in cost of products sold. See accompanying notes to consolidated financial statements. CROMPTON CORPORATION AND SUBSIDIARIES Consolidated Balance Sheets September 30, 2001 (Unaudited) and December 31, 2000 (In thousands of dollars) September 30, December 31, 2001 2000 ASSETS CURRENT ASSETS Cash $ 10,810 $ 20,777 Accounts receivable 257,908 323,097 Inventories 536,479 552,386 Other current assets 184,275 180,635 Total current assets 989,472 1,076,895 NON-CURRENT ASSETS Property, plant and equipment 1,126,788 1,182,087 Cost in excess of acquired net assets 919,205 938,792 Other assets 340,270 330,553 $ 3,375,735 $ 3,528,327 LIABILITIES AND STOCKHOLDERS' EQUITY CURRENT LIABILITIES Notes payable $ 16,257 $ 27,429 Accounts payable 268,571 234,955 Accrued expenses 288,238 306,680 Income taxes payable 108,746 127,950 Other current liabilities 15,118 18,449 Total current liabilities 696,930 715,463 NON-CURRENT LIABILITIES Long-term debt 1,455,865 1,479,394 Postretirement health care liability 205,855 206,469 Other liabilities 339,728 373,025 STOCKHOLDERS' EQUITY Common stock 1,194 1,194 Additional paid-in capital 1,051,554 1,051,371 Accumulated deficit (189,372) (133,864) Accumulated other comprehensive income (112,455) (86,221) Treasury stock at cost (73,564) (78,504) Total stockholders' equity 677,357 753,976 $ 3,375,735 $ 3,528,327 See accompanying notes to consolidated financial statements. CROMPTON CORPORATION AND SUBSIDIARIES Consolidated Statements of Cash Flows (Unaudited) Nine months ended 2001 and 2000 (In thousands of dollars) Increase (decrease) in cash 2001 2000 CASH FLOWS FROM OPERATING ACTIVITIES Net earnings (loss) $ (38,544) $ 92,774 Adjustments to reconcile net earnings (loss) to net cash provided by operations: Facility closures, severance and related costs 103,071 - Depreciation and amortization 140,604 135,968 Equity income (5,466) (10,833) Changes in assets and liabilities, net (90,401) (105,349) Net cash provided by operations 109,264 112,560 CASH FLOWS FROM INVESTING ACTIVITIES Capital expenditures (101,328) (108,136) Merger related expenditures (4,288) (48,798) Other investing activities 6,788 (25,303) Net cash used in investing activities (98,828) (182,237) CASH FLOWS FROM FINANCING ACTIVITIES Proceeds on senior notes - 593,754 Payments on long-term borrowings (22,540) (413,972) Payments on short-term borrowings (12,173) (46,052) Sales (repurchases) of accounts receivable 27,481 (12,928) Treasury stock acquired - (48,453) Dividends paid (16,964) (17,114) Other financing activities 4,319 6,203 Net cash (used in) provided by financing activities (19,877) 61,438 CASH Effects of exchange rate changes on cash (526) (677) Change in cash (9,967) (8,916) Cash at beginning of period 20,777 10,543 Cash at end of period $ 10,810 $ 1,627 See accompanying notes to consolidated financial statements. CROMPTON CORPORATION AND SUBSIDIARIES Notes to Consolidated Financial Statements (Unaudited) PRESENTATION OF CONSOLIDATED FINANCIAL STATEMENTS The information in the foregoing consolidated financial statements is unaudited, but reflects all of the adjustments which, in the opinion of management, are necessary for a fair presentation of the results of operations for the interim periods presented. Included in accounts receivable are allowances for doubtful accounts of $22.4 million at September 30, 2001 and $22.1 million at December 31, 2000. Accumulated depreciation amounted to $641.6 million at September 30, 2001 and $562.6 million at December 31, 2000. Accumulated amortization of cost in excess of acquired net assets amounted to $93.4 million at September 30, 2001 and $73.8 million at December 31, 2000. Accumulated amortization of patents, trademarks and other intangibles included in other assets amounted to $158.3 million at September 30, 2001 and $148.4 million at December 31, 2000. It is suggested that the interim consolidated financial statements be read in conjunction with the consolidated financial statements and notes included in the Company's 2000 Annual Report on Form 10-K. MERGER ACCRUALS As a result of the merger of Crompton and Knowles Corporation and Witco Corporation on September 1, 1999 (the "Merger"), the Company recorded merger related accruals as a component of goodwill, of which $25.3 million remained at December 31, 2000. During the first nine months of 2001, these accruals were reduced by payments of $4.3 million and non-cash charges of $0.7 million. Also, as a result of the Merger, the Company recorded other accruals, of which $7.1 million remained at December 31, 2000. During the first nine months of 2001, payments of $1.8 million and non-cash charges of $0.8 million were made against these other accruals. FACILITY CLOSURES, SEVERANCE AND RELATED COSTS As a result of the cost reduction initiative announced in July 2001, the Company recorded in the third quarter a pre-tax charge for facility closures, severance and related costs of $103.1 million (of which $7.1 million is included in cost of products sold), summarized as follows: Severance Asset Other and	 Write-offs Facility Related and Closure Costs (a) Impairments (b) Costs (c) Total Third quarter charge $35,710 $43,301 $24,060 $103,071 Cash payments (4,532) - (103) (4,635) Non-cash charges (6,706) (43,301) (7,135) (57,142) Balance at Sept. 30, 2001 $24,472 $ - $16,822 $ 41,294 (a) Includes severance at various sites and pension curtailments related to closed sites. (b) Includes primarily asset write-offs and impairments related to closed sites, and the write-down of an equity investment relating to the impairment of assets of an affiliate. (c) Includes primarily demolition, decontamination and decommissioning costs and inventory write-offs related to closed sites. COMMON STOCK As of September 30, 2001, there were 119,372,359 common shares issued and 113,174,323 common shares outstanding at $.01 par value. INVENTORIES Components of inventories are as follows: (In thousands) September 30, December 31, 2001 2000 Finished goods $ 405,830 $ 421,200 Work in process 29,716 29,610 Raw materials and supplies 100,933 101,576 $ 536,479 $ 552,386 EARNINGS PER COMMON SHARE The computation of basic earnings per common share is based on the weighted average number of common shares outstanding. The computation of diluted earnings per common share is based on the weighted average number of common and common equivalent shares outstanding. The following is a reconciliation of the shares used in the computations: (In thousands) Third quarter ended Nine months ended 2001 2000 2001 2000 Weighted average common shares outstanding 113,141 113,599 113,075 113,938 Effect of dilutive stock options and other equivalents - 502 - 1,211 Weighted average common and common equivalent shares outstanding 113,141 114,101 113,075 115,149 COMPREHENSIVE INCOME (LOSS) An analysis of the Company's comprehensive income (loss) follows: (In thousands) Third quarter ended Nine months ended 2001 2000 2001 2000 Net earnings (loss) $ (68,208) $ 21,560 $(38,544) $ 92,774 Other comprehensive income (expense): Foreign currency translation adjustments 19,110 (31,377) (18,937) (43,320) Other (6,766) 34 (7,297) 105 Comprehensive income (loss) $ (55,864) $ (9,783) (64,778) $ 49,559 The components of accumulated other comprehensive income (loss) at September 30, 2001 and December 31, 2000 are as follows: September 30, December 31, (In thousands) 2001 2000 Foreign currency translation adjustments $ (102,770) $ (83,833) Other (9,685) (2,388) Accumulated other comprehensive income (loss) $ (112,455) $ (86,221) DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES Effective January 1, 2001, the Company adopted Statement of Financial Accounting Standards (SFAS) No. 133, "Accounting for Derivative Instruments and Hedging Activities," and SFAS No. 138, "Accounting for Certain Derivative Instruments and Certain Hedging Activities" (the "Statements"). In accordance with the transition provisions of the Statements, the Company recorded in the first quarter an after-tax gain of $346,000 to recognize at fair value all derivatives that were designated as fair value hedging instruments. The pre-tax gain of $567,000 is included in other expense in the statement of operations. The Company also recorded in the first quarter a loss of $234,000 as a component of accumulated other comprehensive income (AOCI) to recognize at fair value all derivatives that were designated as cash flow hedging instruments. The Company also has option contracts that effectively allow it to buy and sell shares of its common stock at various strike prices. Through June 30, 2001, these contracts were recorded on the balance sheet at fair value with changes in market price recorded in earnings. Effective July 2, 2001, due to anticipated volatility in the stock price, the Company designated a portion of its equity option contracts as cash flow hedges of the risk associated with the unvested, unpaid awards under its long-term incentive plans. In accordance with SFAS No. 133, the changes in market value from July 2, 2001 through the balance sheet date, related to the option contracts designated and effective as hedges, have been recorded as a component of AOCI. Such amount, which is subject to changes in the stock price, will be amortized ratably to earnings over the remaining service periods of the hedged long-term incentive plans. Based on the September 30, 2001 market price, the anticipated reclassification to earnings over the next 12 months will be approximately $4.8 million. For the quarter and nine months ended September 30, 2001, the difference between the change in the market value of all fair value hedge contracts and the change in the market value of the hedged items was not significant. For the quarter and nine months ended September 30, 2001, the Company recorded a loss of $6,803,000 and $7,067,000, respectively, as a component of AOCI to recognize the change in fair value of all derivatives that are designated as cash flow hedging instruments. These losses are net of $1.4 million reclassified from AOCI to earnings in the third quarter related to the portion of the option contracts designated and effective as cash flow hedges. BUSINESS SEGMENT DATA (In thousands) Third quarter ended Nine months ended 2001 2000 2001 2000 Net Sales Polymer Products Polymer Additives $ 208,735 $ 238,454 $ 679,262 $ 748,952 Polymers 68,117 82,040 227,049 249,355 Polymer Processing Equipment 40,966 82,464 157,828 231,594 Eliminations (4,113) (2,766) (10,787) (10,195) 313,705 400,192 1,053,352 1,219,706 Specialty Products OrganoSilicones 107,800 119,044 328,277 367,734 Crop Protection 99,851 91,362 332,026 330,706 Other 130,565 127,858 400,234 392,214 338,216 338,264 1,060,537 1,090,654 Total net sales $ 651,921 $ 738,456 $2,113,889 $2,310,360 Operating Profit Polymer Products Polymer Additives $ 9,057 $ 18,883 $ 31,770 $ 63,176 Polymers 11,110 17,335 38,212 55,907 Polymer Processing Equipment (6,719) 7,902 (9,944) 20,090 13,448 44,120 60,038 139,173 Specialty Products OrganoSilicones 13,736 19,358 38,866 66,664 Crop Protection 13,997 14,328 72,889 74,690 Other 7,138 6,591 21,182 22,149 34,871 40,277 132,937 163,503 General corporate expense, including amortization (19,178) (19,185) (58,302) (61,502) Total operating profit before special items 29,141 65,212 134,673 241,174 Facility closures, severance and related costs (103,071) - (103,071) - Total operating profit(loss) $ (73,930) $ 65,212 $ 31,602 $ 241,174 ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS THIRD QUARTER RESULTS Overview Consolidated net sales of $651.9 million for the third quarter of 2001 decreased 12% from the comparable period in 2000. The decrease was primarily the result of the weak domestic economy (including 1% lower pricing) and a 1% negative foreign currency impact, primarily the Euro. Specifically, the Company has been affected by persistent softness in domestic auto production, the dramatic drop in industrial production and significant weakness in capital spending for machinery. International sales, including U.S. exports, were 50% of total sales, up from 46% in the third quarter of 2000. The net loss for the third quarter was $68.2 million, or $0.60 per common share, as compared to net earnings of $21.6 million, or $0.19 per common share, in the third quarter of 2000. Net earnings before after-tax special items were $0.1 million, as compared to $21.6 million, or $0.19 per common share, in the third quarter of 2000. The decrease before special items was primarily due to the impact of lower unit volume and pricing. Gross margin as a percentage of sales was 30.3% for the third quarter of 2001 as compared to 30.8% for the third quarter of 2000. The decrease was primarily due to the inclusion of facility closure costs of $7.1 million in 2001. Consolidated operating loss was $73.9 million as compared to operating profit of $65.2 million for the third quarter of 2000. Consolidated operating profit, excluding the $103.1 million special charge for facility closures, severance and related costs in 2001, decreased 55.3% versus the third quarter of 2000. Polymer Products Polymer additives sales of $208.7 million were down from the prior year by 12%, of which 10% was due to a decline in unit volume, 1% to lower prices and 1% to foreign currency translation. Plastic additives sales declined 8% due mainly to continued weak economic conditions resulting in lower unit volume and lower pricing. Rubber chemicals sales decreased 28% due mainly to a weak automotive market and lower unit sales resulting from a recently announced price increase. In light of this, the Company is reassessing its pricing strategy to maintain its competitiveness in the marketplace. Urethane chemicals sales declined 2% due primarily to lower unit volume. Operating profit of $9.1 million was 52% lower than the third quarter of 2000 due mainly to lower unit volume and lower selling prices. Polymer sales of $68.1 million declined 17% from the third quarter of 2000 due mainly to lower domestic unit volume and a 3% reduction in selling prices. EPDM sales were down 18% due primarily to lower unit volume and lower pricing resulting from continued weakness in domestic automotive and roofing markets. Urethane polymer sales declined 16% due primarily to a decline in industrial production. Operating profit of $11.1 million was down 36% from the third quarter of 2000 due primarily to lower unit volume and lower selling prices, partially offset by lower EPDM raw material costs. Polymer processing equipment sales of $41.0 million were 50% lower than the prior year due primarily to lower unit volume resulting from severe cutbacks in domestic capital spending. The lower sales resulted in an operating loss of $6.7 million, which was $14.6 million worse than the third quarter of 2000. Backlog at the end of September was $97 million, down $8 million from the end of 2000. Specialty Products OrganoSilicones sales of $107.8 million were down 9% from the third quarter of 2000 due to a 5% decline in unit volume mainly attributable to continued weakness in the domestic economy, with the remainder due equally to lower prices and unfavorable foreign currency translation. Operating profit of $13.7 million was 29% lower than the prior year due mainly to lower unit volume, lower selling prices and an unfavorable product mix. Crop protection sales of $99.9 million were up 9% from the third quarter of 2000 due to improved unit volume and a 1% increase in selling prices. Higher international unit volume was responsible for a 20% increase in actives sales which more than offset a 6% decline in surfactants sales. Operating profit of $14.0 million was down 2% from the prior year due primarily to lower joint venture equity income, an unfavorable product mix in surfactants and certain non-recurring income in 2000. Other sales of $130.6 million were up 2% from the third quarter of 2000 mainly as a result of higher petroleum additives sales. Petroleum additives sales rose 15% mainly due to greater demand attributable to a domestic motor oil reformulation. Refined products sales declined 1% due primarily to a reduction in unit volume. Industrial colors and glycerine/fatty acids sales were down 5% and 11%, respectively, due to lower unit volume and lower selling prices. Operating profit of $7.1 million increased 8% from the third quarter of 2000 due mainly to an increase in unit volume and improved sales mix. Other Selling, general and administrative expenses of $105.1 million increased 10% versus the third quarter of 2000. This increase was primarily due to the reversal of performance based compensation costs of $4.8 million in the third quarter of 2000, certain non-recurring income in Crop Protection in 2000 and normal salary and inflationary increases in 2001. Depreciation and amortization increased 4% as a result of a higher fixed asset base. Research and development costs increased less than 2%. Interest expense of $27.3 million decreased 12% mainly due to lower interest rates on the Company's borrowings and a decrease in the debt balance outstanding. The effective tax rate, excluding the impact of special items, was 36% as compared to 31.5% in the comparable quarter of 2000. This increase was primarily due to a tax adjustment recorded in the third quarter of 2000 to properly reduce the effective tax rate for the first nine months of 2000 to 37%. YEAR-TO-DATE RESULTS Overview Consolidated net sales of $2.1 billion for the first nine months of 2001 decreased 9% from the comparable period in 2000. The decrease was primarily the result of the weak domestic economy and a 2% negative foreign currency impact, primarily the Euro. International sales, including U.S. exports, were 49% of total sales, up from 46% for the first nine months of 2000. The net loss for the first nine months of 2001 was $38.5 million, or $0.34 per common share, as compared to net earnings of $92.8 million, or $0.81 per common share, for the first nine months of 2000. Net earnings before after-tax special items were $29.8 million, or $0.26 per common share, as compared to $92.8 million, or $0.81 per common share, for the first nine months of 2000. The decrease before special items was primarily due to the impact of lower sales, higher raw material and energy costs and unfavorable foreign currency impact, offset in part by lower manufacturing costs, the reversal of certain environmental remediation reserves no longer deemed necessary and a pension curtailment gain. Gross margin as a percentage of sales was 30.4% for the first nine months of 2001 as compared to 32.5% for the first nine months of 2000. The decrease was primarily due to higher raw material and energy costs, and the inclusion of facility closure costs ($7.1 million), offset in part by the reversal of certain environmental remediation reserves no longer deemed necessary and a pension curtailment gain. Consolidated operating profit was $31.6 million as compared to operating profit of $241.2 million for the first nine months of 2000. Consolidated operating profit, excluding the $103.1 million special charge for facility closures, severance and related costs, decreased 44.2% versus the first nine months of 2000. Polymer Products Polymer additives sales of $679.3 million were 9% lower than the first nine months of 2000, of which 5% was due to a decline in unit volume, with the balance due equally to lower prices and unfavorable foreign currency translation. Plastic additives sales were down 8% due to lower unit volume and lower pricing attributable to continued weakness in the domestic economy, and unfavorable foreign currency translation. Rubber chemicals sales declined 15% due mainly to continued automotive market weakness and lower unit sales resulting from the recently announced price increases. In light of this, the Company is reassessing its pricing strategy to maintain its competitiveness in the marketplace. Urethane chemicals sales were down 6% due to lower unit volume and unfavorable foreign currency translation. Operating profit of $31.8 million was down 50% from the first nine months of 2000 due mainly to lower unit volume, lower selling prices, and higher raw material and energy costs. Polymer sales of $227.0 million were 9% lower than the first nine months of 2000 due to lower unit volume and unfavorable foreign currency translation of 1%. EPDM sales declined 10% due mainly to continued weak demand in the domestic automotive and roofing markets. Urethane polymer sales decreased 8% due primarily to lower industrial production. Operating profit of $38.2 million declined 32% from the first nine months of 2000 due mainly to lower unit volume, and higher raw material and energy costs. Polymer processing equipment sales of $157.8 million were down 32% from the prior year due mainly to a dramatic reduction in domestic capital equipment spending. The $9.9 million operating loss was $30.0 million worse than the first nine months of 2000 primarily as a result of lower sales. Specialty Products OrganoSilicones sales of $328.3 million were 11% lower than the first nine months of 2000 due to a 7% reduction in unit volume mainly attributable to the weak domestic economy. The remainder was due equally to lower selling prices and lower foreign currency translation. Operating profit of $38.9 million declined 42% from the prior year due primarily to lower unit volume, lower selling prices and an unfavorable product mix. Crop protection sales of $332.0 million were up less than 1% from the prior year as increases in unit volume and selling prices of 1% each were almost entirely offset by unfavorable foreign currency translation. Actives sales rose 5% due primarily to a growth in unit volume, while reduced demand was mainly responsible for a 5% decline in surfactants sales. Operating profit of $72.9 million was 2% lower than the first nine months of 2000 due primarily to an unfavorable surfactants product mix and lower joint venture equity income, offset in part by higher margin actives sales and a pension curtailment gain. Other sales of $400.2 million were up 2% over the first nine months of 2000 due to a 3% increase in prices, partially offset by unfavorable foreign currency translation. Petroleum additives sales were up 10% due primarily to higher unit volume resulting from a domestic motor oil reformulation. Refined products sales rose 4% due mainly to the recovery of increased raw material and energy costs through higher selling prices. Industrial colors and glycerine/fatty acids sales declined 10% and 12%, respectively, due to lower unit volume and lower selling prices. Operating profit of $21.2 million was 4% lower than the prior year as higher raw material and energy costs more than offset improved pricing. Other Selling, general and administrative expenses of $316.8 million decreased 1% versus the first nine months of 2000 primarily as a result of cost savings initiatives and lower foreign currency translation. Depreciation and amortization increased 3% as a result of a higher fixed asset base. Research and development costs decreased 6% primarily as a result of cost savings initiatives. Interest expense of $83.8 million decreased 6% mainly due to lower interest rates on the Company's borrowings and a decrease in the debt balance outstanding. The effective tax rate, excluding the impact of special items, was 36% as compared to 37% for the first nine months of 2000. This decrease was primarily a result of a change in earnings mix to jurisdictions with more favorable tax rates. LIQUIDITY AND CAPITAL RESOURCES The September 30, 2001 working capital balance of $292.5 million decreased $68.9 million from the year-end 2000 balance of $361.4 million, and the current ratio decreased to 1.4 from 1.5. The decreases in working capital and the current ratio were primarily due to a decrease in accounts receivable and an increase in accounts payable. Days sales in receivables decreased to 40 days for the first nine months of 2001, versus 48 days for the first nine months of 2000, primarily due to the impact of accounts receivable securitization programs and an increased focus on collection efforts. Inventory turnover decreased to 3.5 from 3.7 for the same period of 2000 primarily as a result of an accelerating sales decline which more than offset the reduction in inventory. Net cash provided by operations of $109.3 million decreased $3.3 million from the net cash provided by operations of $112.6 million during the first nine months of 2000. The decrease was primarily the result of lower earnings, partially offset by improvements in accounts receivable, inventory and accounts payable. Net cash provided by operations and the reduction in cash, together with proceeds from the sales of accounts receivable and the equity interest in Yorkshire Group PLC, were used primarily to reduce borrowings under the Company's revolving credit agreements, finance capital expenditures and make dividend payments. The Company's debt to total capital ratio increased slightly to 68% from 67% at year-end 2000. The Company's future liquidity needs are expected to be financed from operations. In September 2001, the Company renewed $125 million of its $192 million 364-day senior unsecured revolving credit facility, which is available through September 2002. In addition, the Company amended certain financial covenants relating to its 364-day facility and its $400 million five-year senior unsecured credit facility, which is available through October 2004. Borrowings on these facilities are at various rate options to be determined on the date of borrowing. Borrowings under these agreements amounted to $215 million at September 30, 2001 and carried a weighted average interest rate of 4.22%. In addition, the Company has an accounts receivable securitization program to sell up to $200 million of domestic accounts receivable to agent banks. As of September 30, 2001, $171 million of domestic accounts receivable had been sold under these programs. In addition, the Company's European subsidiaries have three separate agreements to sell accounts receivable to agent banks. The first agreement allows for the sale of up to $32 million of accounts receivable, of which $5 million had been sold as of September 30, 2001. The second agreement allows for the sale of up to $21 million of accounts receivable, of which $13 million had been sold as of September 30, 2001. The third agreement allows for the sale of up to 100% of eligible accounts receivable, of which $57 million had been sold as of September 30, 2001. On March 24, 2001, the Company terminated the $300 million variable interest rate swap contract related to its 8.5% Senior Notes. The Company received $21.9 million of cash proceeds from the settlement of the contract, which represented the market value of the contract on the date of termination. These proceeds were used to pay down debt. In accordance with SFAS No. 133 and SFAS No. 138, as they relate to fair-value hedge accounting, the $21.9 million has been recorded as an increase to the carrying amount of the Senior Notes and will be amortized to earnings over the life of the notes. On March 28, 2001, the Company sold its equity interest in Yorkshire Group PLC for $7 million. The sale resulted in a pre-tax loss of $1.5 million (included in other expense). These proceeds were used to pay down debt. On July 2, 2001, the Company announced a restructuring program that is expected to lower annual operating costs by approximately $60 million by the end of 2002. The savings will be realized through a program of facility consolidation and workforce reduction, together with improvements in procurement and working capital control. During the third quarter, the Company recorded a pre-tax charge of $103.1 million ($68.3 million after-tax) for facility closures, severance and other related costs. Additional related charges (estimated at under $10 million) are expected to be recorded in the fourth quarter as events trigger recognition under generally accepted accounting principles. On October 29, 2001, the Company announced that it will relocate its corporate headquarters from Greenwich to Middlebury, CT by the end of 2002. The Company plans to move personnel during the second half of 2002 and to sublease the Greenwich facility. The Company estimates pre-tax charges of approximately $20 million relating to the move (approximately 50% non-cash), and expects to have pre-tax savings of $8 to $10 million per year. The Company is continuing work on the divestitures of both its Refined Products and Industrial Specialties businesses. The Company anticipates that the divestitures will take additional time due to unfavorable market conditions. The proceeds from these divestitures will be used to pay down debt. Capital expenditures for the first nine months of 2001 amounted to $101.3 million as compared to $108.1 million during the same period of 2000. The decrease is primarily due to a reduction in spending along with the completion of the Greentyre project in Italy. Capital expenditures are expected to approximate $140 million in 2001, primarily related to the Company's replacement needs and expansion and improvement of domestic and foreign facilities. ACCOUNTING DEVELOPMENTS Effective January 1, 2001, the Company adopted the provisions of Statement of Financial Accounting Standards (SFAS) No. 133, "Accounting for Derivative Instruments and Hedging Activities," and SFAS No. 138, "Accounting for Certain Derivative Instruments and Certain Hedging Activities." For further details, see the Derivative Instruments and Hedging Activities footnote included in the Notes to Consolidated Financial Statements (Unaudited) section of this Form 10-Q. In July 2001, the Financial Accounting Standards Board (FASB) issued SFAS No. 141, "Business Combinations" and SFAS No. 142, "Goodwill and Other Intangible Assets." SFAS No. 141 requires that all business combinations initiated after June 30, 2001 be accounted for using the purchase method of accounting. It also specifies criteria that must be met in order for intangible assets acquired in a purchase combination to be recognized apart from goodwill. SFAS No. 142 requires that goodwill and intangible assets with indefinite lives no longer be amortized, but rather be tested for impairment at least annually. Other intangible assets will continue to be amortized over their useful lives. The provisions of SFAS No. 141 are effective immediately, with the exception of transitional provisions related to business combinations initiated prior to June 30, 2001, which are delayed until the adoption of SFAS No. 142. The provisions of SFAS No. 142 are required to be adopted effective January 1, 2002. The Company will apply the transitional provisions of SFAS No. 141 and the provisions of SFAS No. 142 beginning in the first quarter of 2002. The Company will evaluate its existing intangible assets and goodwill and make any necessary reclassifications in order to conform with the new criteria in SFAS No. 141. In accordance with SFAS No. 142, the Company will reassess the useful lives of its intangible assets and will test its goodwill and intangible assets for impairment and recognize any impairment loss as a cumulative effect of change in accounting principle in 2002. The Company expects that the application of the non-amortization provisions of SFAS No. 142 will result in an annual decrease in goodwill amortization expense of approximately $26 million. At this time it is not practicable to estimate the impact of adopting the impairment provisions of SFAS No. 142 on the earnings and financial position of the Company. In August 2001, the FASB issued SFAS No. 143, "Accounting for Asset Retirement Obligations." SFAS No. 143 requires companies to record a liability for asset retirement obligations associated with the retirement of long-lived assets. Such liabilities should be recorded at fair value in the period in which a legal obligation is created, which typically would be upon acquisition or completion of construction. The provisions of SFAS No. 143 are effective for fiscal years beginning after June 15, 2002. The Company is in the process of reviewing the provisions of SFAS No. 143 and has not yet determined what the effect will be on its earnings and financial position. Also in August 2001, the FASB issued SFAS No. 144, "Accounting for the Impairment or Disposal of Long-Lived Assets." SFAS No. 144 supercedes SFAS No. 121, "Accounting for the Impairment of Long-Lived Assets and for Long-Lived Assets to be Disposed of." SFAS No. 144 retains the fundamental provisions of SFAS No. 121 related to the recognition and measurement of the impairment of long-lived assets to be held and used and the measurement of long-lived assets to be disposed of, but excludes goodwill from its scope and provides additional guidance on the accounting for long-lived assets held for sale. The provisions of SFAS No. 144 are effective for fiscal years beginning after December 15, 2001. The Company does not expect that the impact of the implementation of SFAS No. 144 will materially differ from the impact of the existing requirements under SFAS No. 121. ENVIRONMENTAL MATTERS The Company is involved in claims, litigation, administrative proceedings and investigations of various types in a number of jurisdictions. A number of such matters involve claims for a material amount of damages and relate to or allege environmental liabilities, including clean-up costs associated with hazardous waste disposal sites, natural resource damages, property damage and personal injury. The Company and some of its subsidiaries have been identified by federal, state or local governmental agencies, and by other potentially responsible parties (each a "PRP") under the Comprehensive Environmental Response, Compensation and Liability Act of 1980, as amended, or comparable state statutes, as a PRP with respect to costs associated with waste disposal sites at various locations in the United States. In addition, the Company is involved with environmental remediation and compliance activities at some of its current and former sites in the United States and abroad. The Company continually evaluates and reviews estimates for future remediation and other costs to determine appropriate environmental reserve amounts. For each site, a determination is made of the specific measures that are believed to be required to remediate the site, the estimated total cost to carry out the remediation plan, the portion of the total remediation costs to be borne by the Company and the anticipated time frame over which payments toward the remediation plan will occur. As of September 30, 2001, the Company's reserves for environmental remediation activities totaled $142 million. It is possible that the Company's estimates for environmental remediation liabilities may change in the future should additional sites be identified, further remediation measures be required or undertaken, the interpretation of current laws and regulations be modified or additional environmental laws and regulations be enacted. The Company intends to assert all meritorious legal defenses and all other equitable factors which are available to it with respect to the above matters. The Company believes that the resolution of these environmental matters will not have a material adverse effect on its consolidated financial position. While the Company believes it is unlikely, the resolution of these environmental matters could have a material adverse effect on the Company's consolidated results of operations in any given year if a significant number of these matters are resolved unfavorably. EURO CONVERSION On January 1, 1999, certain member countries of the European Union adopted the Euro as their common legal currency. Between January 1, 1999 and December 31, 2001, transactions may be conducted in either the Euro or the participating countries national currency. However, by January 1, 2002, the participating countries will withdraw their national currency as legal tender and complete the conversion to the Euro. The Company conducts business in Europe and does not expect the conversion to the Euro to have an adverse effect on its competitive position or consolidated financial position. FORWARD-LOOKING STATEMENTS Certain statements made in this Form 10-Q are forward-looking statements that involve risks and uncertainties, including, but not limited to, general economic conditions, energy and raw material prices and availability, production capacity, changes in interest rates and foreign currency exchange rates, changes in technology, market demand and customer requirements, expected restructuring activities and cost reductions, the enactment of more stringent environmental laws and regulations, and other risks and uncertainties detailed in the Company's filings with the Securities and Exchange Commission. These statements are based on currently available information and the Company's actual results may differ significantly from the results discussed. Forward-looking information is intended to reflect opinions as of the date this Form 10-Q was issued and such information will not necessarily be updated by the Company. ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURE OF MARKET RISK Refer to the Market Risk & Risk Management Policies section of Management's Discussion and Analysis of Financial Condition and Results of Operations included in the Company's Annual Report on Form 10-K for the year ended December 31, 2000. The fair market value of long-term debt is subject to interest rate risk. The Company's long-term debt amounted to $1,456 million at September 30, 2001. The fair market value of such debt was $1,482 million which has been determined primarily based on quoted market prices. On March 24, 2001, the Company terminated the $300 million variable interest rate swap contract related to its 8.5% Senior Notes. The Company received $21.9 million of cash proceeds from the settlement of the contract, which represented the market value of the contract on the date of termination. In accordance with SFAS No. 133 and SFAS No. 138, as they relate to fair-value hedge accounting, the $21.9 million has been recorded as an increase to the carrying amount of the Senior Notes and will be amortized to earnings over the life of the notes. Effective July 2, 2001, due to anticipated volatility in the stock price, the Company designated a portion of its equity option contracts as cash flow hedges of the risk associated with the unvested, unpaid awards under its long-term incentive plans. In accordance with SFAS No. 133, the changes in market value from July 2, 2001 through the balance sheet date, related to the option contracts designated and effective as hedges, have been recorded as a component of AOCI. Such amount, which is subject to changes in the stock price, will be amortized ratably to earnings over the remaining service periods of the hedged long-term incentive plans. Based on the September 30, 2001 market price, the anticipated reclassification to earnings over the next 12 months will be approximately $4.8 million. There have been no other significant changes in market risk since December 31, 2000. PART II. OTHER INFORMATION ITEM 1. Legal Proceedings (i) Reference is made to Item 3 of the Registrant's Annual Report on Form 10-K for the fiscal year ended December 31, 2000, to Part II, Item 1(i) of the Registrant's Quarterly Report on Form 10-Q for the quarter ended March 31, 2001, and to Part II, Item 1(i) of the Registrant's Quarterly Report on Form 10-Q for the quarter ended June 30, 2001, for information relating to the Vertac Chemical Corporation site in Jacksonville, Arkansas. On September 4, 2001, the Registrant filed a Petition for a Writ of Certiorari with the United States Supreme Court relating to a finding of arranger liability against Uniroyal by the United States Court of Appeals for the Eighth Circuit ("Court"). On October 9, 2001, the trial court commenced hearings pursuant to the April 10, 2001, remand by the Court. ITEM 6. Exhibits and Reports on Form 8-K (a) Exhibits Number Description 4.1 $125,000,000 Amended and Restated 364-Day Credit Agreement dated as of September 24, 2001, among the Registrant, certain subsidiaries of the Registrant, various banks, The Chase Manhattan Bank, as Syndication Agent, Citibank, N.A., as Administrative Agent, Bank of America, N.A., as Documentation Agent and J.P. Morgan Securities Inc., as Lead Arranger and Sole Bookrunner. 4.2 First Amendment dated as of September 24, 2001 to the Five-Year Credit Agreement dated as of October 28, 1999, among the Registrant, certain subsidiaries of the Registrant, various banks, The Chase Manhattan Bank, as Syndication Agent, Citibank, N.A., as Administrative Agent, Bank of America, N.A. and Deutsche Bank Alex Brown Inc., as Co-Documentation Agents, and J.P. Morgan Securities Inc., as Lead Arranger and Sole Bookrunner. (b) No reports on Form 8-K were filed during the quarter for which this report is filed. CROMPTON CORPORATION Signatures Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. CROMPTON CORPORATION (Registrant) /s/Peter Barna Date: November 13, 2001 Peter Barna Senior Vice President and Chief Financial Officer /s/Barry J. Shainman Date: November 13, 2001 Barry J. Shainman Secretary